The Functional Topography of Transmembrane Domain 3 of the M1 Muscarinic Acetylcholine Receptor, Revealed by Scanning Mutagenesis*
暂无分享,去创建一个
E C Hulme | E. Hulme | Z L Lu | Zhi-Liang Lu
[1] A. Scheer,et al. Constitutively active mutants of the alpha 1B‐adrenergic receptor: role of highly conserved polar amino acids in receptor activation. , 1996, The EMBO journal.
[2] Jonathan A Javitch,et al. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method , 1995, Neuron.
[3] H. Khorana,et al. Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. , 1995, Biochemistry.
[4] T L Blundell,et al. The evolution and structure of aminergic G protein-coupled receptors. , 1994, Receptors & channels.
[5] C. Fraser,et al. Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function. , 1992, The Journal of biological chemistry.
[6] E. Hulme,et al. The role of the aspartate-arginine-tyrosine triad in the m1 muscarinic receptor: mutations of aspartate 122 and tyrosine 124 decrease receptor expression but do not abolish signaling. , 1997, Molecular pharmacology.
[7] J. Wess,et al. Site‐directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. , 1991, The EMBO journal.
[8] D. Oprian,et al. Constitutively active mutants of rhodopsin , 1992, Neuron.
[9] M. Brann,et al. The Second Intracellular Loop of the m5 Muscarinic Receptor Is the Switch Which Enables G-protein Coupling* , 1998, The Journal of Biological Chemistry.
[10] L. Birnbaumer,et al. Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. , 1994, Molecular pharmacology.
[11] O. Lichtarge,et al. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F , 1996, Nature.
[12] J. W. Wells,et al. Constitutive activation of the m5 muscarinic receptor by a series of mutations at the extracellular end of transmembrane 6. , 1997, Biochemistry.
[13] S. Lazareno,et al. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. , 1995, Molecular pharmacology.
[14] R. Lefkowitz,et al. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.
[15] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[16] H. Khorana,et al. Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.
[17] J. Black,et al. Operational models of pharmacological agonism , 1983, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[18] T. Clackson,et al. A hot spot of binding energy in a hormone-receptor interface , 1995, Science.
[19] E. Hulme,et al. The function of a highly-conserved arginine residue in activation of the muscarinic M1 receptor. , 1995, European journal of pharmacology.
[20] E. Hulme,et al. Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation. , 1990, The Journal of biological chemistry.
[21] E C Hulme,et al. Acetylcholine mustard labels the binding site aspartate in muscarinic acetylcholine receptors. , 1994, The Journal of biological chemistry.
[22] B. Kobilka,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[23] E. Hulme,et al. Scanning mutagenesis of transmembrane domain 3 of the m1 muscarinic acetylcholine receptor , 1998, Journal of Physiology-Paris.
[24] E. El-Fakahany,et al. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor. , 1994, Molecular pharmacology.
[25] J. Baldwin,et al. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.
[26] A. Fersht,et al. Protein engineering and the study of structure--function relationships in receptors. , 1990, Trends in pharmacological sciences.
[27] D. Oprian,et al. Constitutive activation of opsin: influence of charge at position 134 and size at position 296. , 1993, Biochemistry.
[28] K. Page,et al. The functional role of the binding site aspartate in muscarinic acetylcholine receptors, probed by site-directed mutagenesis. , 1995, European journal of pharmacology.
[29] Robert P. Millar,et al. Functional Microdomains in G-protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[30] D. A. Dougherty,et al. Cation-π Interactions in Chemistry and Biology: A New View of Benzene, Phe, Tyr, and Trp , 1996, Science.
[31] J Hoflack,et al. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. , 1991, Molecular pharmacology.
[32] K. Fahmy,et al. Regulation of the rhodopsin-transducin interaction by a highly conserved carboxylic acid group. , 1993, Biochemistry.